Nitric Oxide-Donating Genistein Prodrug: Design, Synthesis, and Bioactivity on MC3T3-E1 Cells
To find a more potent alternative with less estrogen-related side effects for hormone replacement therapy, we designed and synthesized a nitric oxide (NO)-releasing prodrug of genistein, named NO-donating genistein (NO-G). The characteristics of NO-G were determined by melting point, NMR spectroscop...
Main Authors: | , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2007-01-01
|
Series: | Journal of Pharmacological Sciences |
Online Access: | http://www.sciencedirect.com/science/article/pii/S1347861319342811 |
id |
doaj-4acd1a3bd8714199977a21defd197501 |
---|---|
record_format |
Article |
spelling |
doaj-4acd1a3bd8714199977a21defd1975012020-11-24T21:49:18ZengElsevierJournal of Pharmacological Sciences1347-86132007-01-0110418289Nitric Oxide-Donating Genistein Prodrug: Design, Synthesis, and Bioactivity on MC3T3-E1 CellsJiepin Wang0Fujun Shang1Ru Jiang2Li Liu3Siwang Wang4Jin Hou5Menglei Huan6Qibing Mei7Department of Pharmacology, Xi’an, Shaanxi, 710032, China; Institute of Materia Medica, School of Pharmacy, Fourth Military Medical University, Xi’an, Shaanxi, 710032, ChinaDepartment of Cardiology, Tangdu Hospital, Fourth Military Medical University, Xi’an, Shaanxi, 710038, ChinaDepartment of Chemistry, Xi’an, Shaanxi, 710032, ChinaDepartment of Pharmacology, Xi’an, Shaanxi, 710032, ChinaInstitute of Materia Medica, School of Pharmacy, Fourth Military Medical University, Xi’an, Shaanxi, 710032, ChinaDepartment of Pharmacology, Xi’an, Shaanxi, 710032, ChinaDepartment of Pharmacology, Xi’an, Shaanxi, 710032, ChinaDepartment of Pharmacology, Xi’an, Shaanxi, 710032, China; Corresponding author. pharm-mei@hotmail.comTo find a more potent alternative with less estrogen-related side effects for hormone replacement therapy, we designed and synthesized a nitric oxide (NO)-releasing prodrug of genistein, named NO-donating genistein (NO-G). The characteristics of NO-G were determined by melting point, NMR spectroscopy, and mass spectrometric analysis. HPLC has been used to test the new prodrug’s stability. The releasing capacity of NO-G was tested by Griess reagent in vitro. The bioactivities of NO-G on proliferation, differentiation, and mineralization of the osteoblastic cell line MC3T3-E1 were determined by MTT assay, flow cytometric analysis, measurement of the alkaline phosphatase (ALP) activity and the secreted osteocalcin (OCN), and Alizarin Red-S staining. The product showed 1H NMR spectra and relative molecular mass in agreement with the designed structure, and it was stable in buffer solution. NO-G continually released low level NO within 5 h in MC3T3-E1 cells. NO-G caused a significant elevation of cell growth, ALP activity, and OCN secretion in both dose- and time-dependent manner. Furthermore, the Alizarin Red-S staining showed that NO-G promoted mineralization of MC3T3-E1 cells. These effects were all significantly greater than those of its parent drugs. The results suggested that NO-G might be a novel drug for the treatment of postmenopausal osteoporosis. Keywords:: postmenopausal osteoporosis, nitric oxide (NO)-releasing prodrug, synthesis, MC3T3-E1 cell, bioactivityhttp://www.sciencedirect.com/science/article/pii/S1347861319342811 |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Jiepin Wang Fujun Shang Ru Jiang Li Liu Siwang Wang Jin Hou Menglei Huan Qibing Mei |
spellingShingle |
Jiepin Wang Fujun Shang Ru Jiang Li Liu Siwang Wang Jin Hou Menglei Huan Qibing Mei Nitric Oxide-Donating Genistein Prodrug: Design, Synthesis, and Bioactivity on MC3T3-E1 Cells Journal of Pharmacological Sciences |
author_facet |
Jiepin Wang Fujun Shang Ru Jiang Li Liu Siwang Wang Jin Hou Menglei Huan Qibing Mei |
author_sort |
Jiepin Wang |
title |
Nitric Oxide-Donating Genistein Prodrug: Design, Synthesis, and Bioactivity on MC3T3-E1 Cells |
title_short |
Nitric Oxide-Donating Genistein Prodrug: Design, Synthesis, and Bioactivity on MC3T3-E1 Cells |
title_full |
Nitric Oxide-Donating Genistein Prodrug: Design, Synthesis, and Bioactivity on MC3T3-E1 Cells |
title_fullStr |
Nitric Oxide-Donating Genistein Prodrug: Design, Synthesis, and Bioactivity on MC3T3-E1 Cells |
title_full_unstemmed |
Nitric Oxide-Donating Genistein Prodrug: Design, Synthesis, and Bioactivity on MC3T3-E1 Cells |
title_sort |
nitric oxide-donating genistein prodrug: design, synthesis, and bioactivity on mc3t3-e1 cells |
publisher |
Elsevier |
series |
Journal of Pharmacological Sciences |
issn |
1347-8613 |
publishDate |
2007-01-01 |
description |
To find a more potent alternative with less estrogen-related side effects for hormone replacement therapy, we designed and synthesized a nitric oxide (NO)-releasing prodrug of genistein, named NO-donating genistein (NO-G). The characteristics of NO-G were determined by melting point, NMR spectroscopy, and mass spectrometric analysis. HPLC has been used to test the new prodrug’s stability. The releasing capacity of NO-G was tested by Griess reagent in vitro. The bioactivities of NO-G on proliferation, differentiation, and mineralization of the osteoblastic cell line MC3T3-E1 were determined by MTT assay, flow cytometric analysis, measurement of the alkaline phosphatase (ALP) activity and the secreted osteocalcin (OCN), and Alizarin Red-S staining. The product showed 1H NMR spectra and relative molecular mass in agreement with the designed structure, and it was stable in buffer solution. NO-G continually released low level NO within 5 h in MC3T3-E1 cells. NO-G caused a significant elevation of cell growth, ALP activity, and OCN secretion in both dose- and time-dependent manner. Furthermore, the Alizarin Red-S staining showed that NO-G promoted mineralization of MC3T3-E1 cells. These effects were all significantly greater than those of its parent drugs. The results suggested that NO-G might be a novel drug for the treatment of postmenopausal osteoporosis. Keywords:: postmenopausal osteoporosis, nitric oxide (NO)-releasing prodrug, synthesis, MC3T3-E1 cell, bioactivity |
url |
http://www.sciencedirect.com/science/article/pii/S1347861319342811 |
work_keys_str_mv |
AT jiepinwang nitricoxidedonatinggenisteinprodrugdesignsynthesisandbioactivityonmc3t3e1cells AT fujunshang nitricoxidedonatinggenisteinprodrugdesignsynthesisandbioactivityonmc3t3e1cells AT rujiang nitricoxidedonatinggenisteinprodrugdesignsynthesisandbioactivityonmc3t3e1cells AT liliu nitricoxidedonatinggenisteinprodrugdesignsynthesisandbioactivityonmc3t3e1cells AT siwangwang nitricoxidedonatinggenisteinprodrugdesignsynthesisandbioactivityonmc3t3e1cells AT jinhou nitricoxidedonatinggenisteinprodrugdesignsynthesisandbioactivityonmc3t3e1cells AT mengleihuan nitricoxidedonatinggenisteinprodrugdesignsynthesisandbioactivityonmc3t3e1cells AT qibingmei nitricoxidedonatinggenisteinprodrugdesignsynthesisandbioactivityonmc3t3e1cells |
_version_ |
1725888186943537152 |